For UK Consultants & Registrars in Dermatology and Plastic Surgery
Clinical decision support for UK skin oncology. From AJCC 8th staging and risk scoring to secure clinical photography, lesion localisation, and patient information resources.
Selected modules from the wider Dermafocal clinical toolkit.
Differential diagnosis support and risk stratification for trained clinicians.
Structured management outputs and MDT-oriented guidance across key tumour pathways.
AJCC 8th staging and risk tools for melanoma, cSCC, Merkel cell carcinoma, adnexal carcinoma, sarcoma, and more.
Secure local-first clinical photography with consent-aware workflow and record export.
Anatomical lesion localisation and site documentation to support accurate record keeping.
Condition and procedure leaflets for diagnosis, surgery, aftercare, and consent support.
Dermafocal is built for UK clinical practice across both NHS and private settings, with emphasis on patient safety, regulatory clarity, and local-first data handling. Developed by a UK consultant plastic surgeon specialising in skin oncology.
Class I Medical Device (Ref: 2026020301462324). UKCA Marked. Verify on MHRA
Clinical safety documentation, hazard logging, and governance review maintained to support safe deployment.
Structured to support DTAC-aligned procurement and deployment discussions with NHS organisations.
Local-first architecture keeps Derma Capture records on device in normal operation and avoids a routine central clinical storage backend.
We can support departmental licensing conversations via Apple Business Manager or direct procurement discussion.
Dermafocal is maintained with clinical review, source mapping, automated tests, and post-release governance to support specialist verification.
Core staging engines, risk tools, and calculators are supported by automated boundary-condition tests and ongoing clinician review.
Clinical thresholds are checked against relevant sources such as AJCC 8th Edition, BAD, NICE NG14, NCCN, and anaesthetic safety guidance, with corrections tracked through release governance.
Clinical tools and patient information surfaces provide source citations or source pathways so clinicians can verify the evidence base behind outputs.
Clinical safety documentation and hazard logging are maintained to support DCB0129-style governance and post-market review.
Individual subscriptions for clinicians, with annual pricing offering the best value.